Global Non-Invasive Prenatal Testing (NIPT) Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034)

Non-Invasive Prenatal Testing (NIPT) Market Outlook

• The rising demand for safe and reliable prenatal testing methods that allow the early detection of chromosomal abnormalities is expected to boost the market growth.
• The increase in the number of older expectant mothers and the growing public awareness are driving the demand for advanced prenatal screening methods.
• Technological advancements in genomic sequencing and bioinformatics are likely to make these tests more accessible and cost-effective, thereby contributing to market expansion.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Non-Invasive Prenatal Testing (NIPT) Market Overview

Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening (NIPS), is a method of analyzing the risk of genetic abnormalities in the fetus. It is a safe and highly effective method of screening the conditions for Down syndrome, Edwards syndrome, Patau syndrome, and Turner syndrome, among others. This is generally done by analyzing small fragments of DNA, circulating in pregnant women’s blood by 10 weeks of pregnancy.

The increasing government spending on research and development (R&D) activities on prenatal screening is expected to drive the growth of the non-invasive prenatal testing (NIPT) market. Various laboratories and companies are providing advanced non-invasive prenatal testing (NIFT) to patients, which is propelling the expansion of the market. Moreover, the rising incidences of genetic disorders, the increasing public healthcare expenditure, and growing awareness are estimated to fuel the market growth in the forecast period.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Non-Invasive Prenatal Testing (NIPT) Market Growth Drivers

High Risk of Chromosomal Abnormalities Driving the Market Growth

The high risk of chromosomal abnormalities and the increasing maternal age are propelling the growth of the market. As pregnancy above 35 years has a higher risk of genetic abnormalities, the demand for non-invasive prenatal testing (NIPT) is increasing. Obstetricians are increasingly recommending patients undergo non-invasive tests to ensure healthy delivery of babies, hence positively impacting the market growth.

Non-Invasive Prenatal Testing (NIPT) Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Increased Research Activities to Affect the Market Landscape Significantly

The market is witnessing increased research activities for the development of advanced technologies for NIPT, which is projected to support market growth. With technological advancements, the cost-effectiveness of non-invasive prenatal testing (NIPT) is increasing, which is likely to bolster the market demand in upcoming years.

Rising Investments to Augment Non-Invasive Prenatal Testing (NIPT) Market Size

In June 2024 , California-based BillionToOne, a precision diagnostics company, secured USD 130 million in an oversubscribed, upsized Series D financing round led by prominent investors. The company plans to use the venture capital funding to expand its non-invasive prenatal screening and oncology diagnostics businesses. Such major investments in prenatal screening are set to boost market growth. 

Rising Development of Advanced Foetal Tests to Elevate the Non-Invasive Prenatal Testing (NIPT) Market Value
In July 2024 , Italian pharmaceutical company Menarini reported positive results from a clinical study investigating its non-invasive prenatal testing technology on more than 1000 women. The company announced that its non-invasive test can detect foetal abnormalities with higher accuracy and sensitivity in comparison to standard non-invasive prenatal cell-free DNA (cfDNA) screening. The rising development of such screening tests that exhibit higher resolution and accuracy is poised to elevate the market value.

Expansion Beyond High-Risk Pregnancies Likely to Boost Non-Invasive Prenatal Testing (NIPT) Market Demand
Initially, in cases of high-risk pregnancies, non-invasive prenatal testing was recommended for expectant mothers. However, there is a growing shift towards the use of these tests for all pregnant women, irrespective of risk factors. This trend, supported by the growing awareness about the benefits of early and accurate screening, is anticipated to augment market demand.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Non-Invasive Prenatal Testing (NIPT) Market Segmentation

Market Breakup by Product Type

• Instruments
• Consumables
• Reagents

Market Breakup by Technology

• Next Generation Sequencing (NGS)
• Microarray
• Polymerase Chain Reaction (PCR)
• Rolling Circular Amplification

Market Breakup by Application

• Down Syndrome
• Edwards Syndrome
• Patau Syndrome
• Turner Syndrome
• Others

Market Breakup by End User

• Hospitals
• Diagnostic Labs
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Non-Invasive Prenatal Testing (NIPT) Market Share

The Technology Segment Represents Substantial Market Share

Based on the technology, the market is segmented into next-generation sequencing (NGS), microarray, polymerase chain reaction (PCR), and rolling circular amplification. Next-generation sequencing is a dominant technology in the market due to its ability to analyze multiple genes and detect chromosomal abnormalities with high accuracy. Microarray technology is cost-effective and quick and allows screening for specific genetic markers associated with chromosomal abnormalities. However, microarray does not offer the same depth of information as NGS technology.

Non-Invasive Prenatal Testing (NIPT) Market Analysis by Region

North America holds a significant share of the market which can be attributed to the high preterm birth rate, the robust healthcare infrastructure, and the rising disposable income. The increasing incidences of chromosomal abnormalities and the rising awareness regarding the benefits of non-invasive prenatal testing (NIPT) are also propelling the growth of the market. Moreover, with the growing focus of the leading companies on expanding their offerings of non-invasive prenatal testing (NIPT), the market value is likely to experience a surge. Additionally, the introduction of new and technologically advanced tests is significantly contributing to the market growth in this region.

Meanwhile, the Asia Pacific region is also expected to grow significantly in the forecast period, owing to the developing healthcare infrastructure in emerging countries such as Japan and India, among others. The increasing public healthcare expenditure and the rising awareness regarding non-invasive prenatal testing (NIPT) are anticipated to invigorate the market growth. Moreover, technological advancements and innovations in non-invasive prenatal testing (NIPT) are estimated to propel the market expansion in the region.

Leading Players in the Non-Invasive Prenatal Testing (NIPT) Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Illumina Inc.

Headquartered in San Diego, California, Illumina is one of the leading biotechnology companies known for its array-based solutions for DNA, RNA, and protein analysis. The company provides advanced sequencing systems such as the NextSeq and NovaSeq platforms, which are widely used for non-invasive prenatal testing.

Thermo Fisher Scientific Corporation

This American-headquartered life science and clinical research company is a global supplier of analytical instruments, chemicals, and consumables, among others. Thermo Fisher's Ion Torrent NGS platforms and AmpliSeq technology for targeted DNA sequencing can help in ensuring accurate prenatal screening.

PerkinElmer Inc.

PerkinElmer, a global provider of technology and service solutions, has a prominent presence in the market and is focused on strengthening its capabilities in molecular diagnostics. The company leverages collaborations with hospitals and clinics to expand its market reach.

Agilent Technologies, Inc.

American global company Agilent Technologies provides instruments, software, and services, as well as consumables for laboratories. The company offers microarray-based solutions which can be used for prenatal testing.

Other key players in the market include F. Hoffmann-La Roche AG, BGI Group, Eurofins Scientific SE, Invitae Corporation, Centogene NV, MedGenome Labs Ltd, Myriad Womens Health Inc., and Qiagen NV.

Key Questions Answered in the Global Non-Invasive Prenatal Testing (NIPT) Market Report

• What was the global non-invasive prenatal testing (NIPT) market value in 2023?
• What is the global non-invasive prenatal testing (NIPT) market forecast outlook for 2025-2034?
• What are the regional markets covered in the EMR report?
• What is market segmentation based on product?
• What is the market breakup based on technology?
• What is the market breakup by application?
• Who are the major end users in the market?
• What are the major factors aiding the global non-invasive prenatal testing (NIPT) market demand? 
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• How does the increasing maternal age affect the market landscape?
• What are the major global non-invasive prenatal testing (NIPT) market trends?
• How do the advances in genomics impact the market size?
• Which product will dominate the market share? 
• Which technology is expected to have a high market value in the coming years?
• Which application will experience the highest demand in the market segment?
• Which end user is projected to contribute to the highest market growth?
• Who are the key players involved in the non-invasive prenatal testing (NIPT) market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?